Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)

Phase

N/A

Condition

Williams Syndrome

Stress

Circulation Disorders

Treatment

Regret Lottery

Control Condition

Clinical Study ID

NCT04114669

19-00952

Ages > 18
All Genders

Study Summary

BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospitals (NYC-H+H) system and NYU Langone Family Health Centers. The trial will recruit from 3 NYC-H+H ambulatory clinics as well as NYU Langone Family Health Centers, and will use a lottery incentive program to promote adherence to antihypertensive medication that will be delivered via smartphone for 6 months. The trial will randomize 435 patients with hypertension determined to have poor adherence (<80% adherence with antihypertensive medication), in a 2:1 (intervention:control) ratio. Baseline enrollment will occur over 36 months with an expected 12 months follow-up per participant.

Eligibility Criteria

Inclusion

Inclusion Criteria:

A diagnosis of hypertension.
An active prescription for ≥1 antihypertensive medication (any of the followingclasses: thiazide diuretic, ACE inhibitor, angiotensin receptor blocker, betablocker, calcium channel blocker, centrally acting alpha agonist, directvasodilator).
1 ambulatory systolic blood pressure ≥140 mmHg (on therapy).
Suboptimal adherence (self-report).

Exclusion

Exclusion Criteria:

Incarcerated
Pregnant
Unable to use study software (Way To Health) in English or Spanish
Unable/unwilling to consent
Clear barrier to technology use (e.g. visual or hearing impairment)
Projected life expectancy <12 months

Study Design